https://www.selleckchem.com/pr....oducts/oxidopamine-h
count of non-opioid prescriptions within 90 days, overall, and by sub-class. The intervention was not associated with the likelihood of patients receiving at least one prescription for new non-opioid pain-related medications, overall (adjusted OR, 1.02; 95% CI, 0.97-1.08) or by sub-class. The intervention was not associated with the number of prescriptions for any non-opioid medication (adjusted incidence rate ratio [IRR], 1.02; 95% CI, 0.99-1.04). However, the intervention was associated with more new prescriptions for
Curtir
Comentario
Compartilhar
